[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-oruka-therapeutics-soars-12-as-psoriasis-drug-clears-skin-in-61-of-high-dose-patients-a-paradigm-shift-EN":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":344},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},145834,"Oruka Therapeutics Soars 12% as Psoriasis Drug Clears Skin in 61% of High-Dose Patients: “A Paradigm Shift”","2026-10-26T17:45:27","2026-10-26T17:45:34","\u003Cp>Now December has to deliver\u003C\u002Fp>\n","\n\u003Ch2 id=\"h-key-takeaways\" class=\"wp-block-heading\">Key Takeaways\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Oruka Therapeutics shares rose 12% after ORKA-001, its drug for psoriasis, completely cleared the skin of 61% of patients on the high dose at Week 16 of its Phase 2b EVERLAST-B trial.\u003C\u002Fli>\n\n\n\n\u003Cli>The results closely match the earlier EVERLAST-A trial, so the drug’s efficacy looks much more solid now.\u003C\u002Fli>\n\n\n\n\u003Cli>The bigger prize is dosing: Oruka is aiming for one or two shots a year. AbbVie’s Skyrizi is given every 12 weeks and Johnson & Johnson’s Tremfya every 8.\u003C\u002Fli>\n\n\n\n\u003Cli>The next test is the 52-week EVERLAST-A data due in December, and Phase 3 is planned for the first half of 2027.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Oruka Therapeutics (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=1877171755&tid=1892924454\">ORKA\u003C\u002Fa>)\u003C\u002Fstrong> is up 12% today after its psoriasis drug passed its second big test, with results that look a lot like the first.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-round-two-looks-like-round-one\" class=\"wp-block-heading\">Round two looks like round one\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Early this morning, Oruka reported Week 16 results from EVERLAST-B, its Phase 2b trial of ORKA-001. These are the results for the 600 mg group, the dose it plans to take into Phase 3:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>61% of patients reached PASI 100, or completely clear skin (the trial’s main goal), against 0% on placebo.\u003C\u002Fli>\n\n\n\n\u003Cli>86% reached PASI 90.\u003C\u002Fli>\n\n\n\n\u003Cli>39% had at least one adverse event, against 43% on placebo, and none had a serious one.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">That’s right in line with the earlier EVERLAST-A trial, where 63% of high-dose patients reached PASI 100 at Week 16.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR tracks 13 analysts on Oruka Therapeutics. How many say “Buy”?\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">See the full breakdown of Buy, Hold, and Sell ratings on Oruka Therapeutics, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fvaluation-model-builder?ref=tikrblog\">See Oruka Therapeutics’ Analyst Ratings\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-one-or-two-shots-a-year\" class=\"wp-block-heading\">One or two shots a year\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Oruka is aiming to dose ORKA-001 just once or twice a year. Skyrizi, from \u003Cstrong>AbbVie (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=141885706&tid=225079155\">ABBV\u003C\u002Fa>)\u003C\u002Fstrong>, is given every 12 weeks, and Tremfya, from \u003Cstrong>Johnson & Johnson (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=139677&tid=2623227\">JNJ\u003C\u002Fa>)\u003C\u002Fstrong>, every 8.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Joel Gelfand, a University of Pennsylvania dermatology professor and EVERLAST-B’s lead investigator, said in Oruka’s release:\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">“The potential for these effects to be long lasting, with just one or two doses a year, would be a paradigm shift in moderate-to-severe psoriasis management.”\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Plus: Oruka says ORKA-001’s PASI 100 rate across its two trials runs about 20 points above what the leading IL-23 drugs have shown in their own trials. (That comparison is across separate trials; no head-to-head study has been run.) And by Oruka’s count, psoriasis has already produced several drugs with $5 billion or more in yearly sales.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-december-is-the-next-big-test\" class=\"wp-block-heading\">December is the next big test\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Oruka expects 52-week EVERLAST-A results in December, a first look at whether the response can last on a shot once a year. Phase 3 should start in the first half of 2027.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">And it has the cash to get there…\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3024\" height=\"2016\" data-public-id=\"images\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3024,h_2016,c_scale\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA\" alt=\"Bar chart from TIKR of Oruka Therapeutics' cash and short-term investments, $ millions, last 8 quarters (to June 30, 2026).\" class=\"wp-post-145834 wp-image-145827\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1793030989\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA 3024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_800,c_scale\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1793030989\u002Fimages\u002FORKA-2026-10-26_ORKA_cash_8q\u002FORKA-2026-10-26_ORKA_cash_8q.png?_i=AA 300w\" sizes=\"auto, (max-width: 3024px) 100vw, 3024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Oruka Therapeutics (ORKA): cash and short-term investments, $ millions, last 8 quarters (to June 30, 2026) (\u003Cstrong>TIKR\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">That pile more than doubled in the June quarter, and Oruka says it should last through filing ORKA-001 for approval. Meanwhile, the burn has run $21 million to $24 million a quarter lately…\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3024\" height=\"2016\" data-public-id=\"images\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3024,h_2016,c_scale\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA\" alt=\"Bar chart from TIKR of Oruka Therapeutics' free cash flow, $ millions, last 7 quarters (to March 31, 2026).\" class=\"wp-post-145834 wp-image-145831\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1793030972\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA 3024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_800,c_scale\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1793030972\u002Fimages\u002FORKA-2026-10-26_ORKA_fcf_8q\u002FORKA-2026-10-26_ORKA_fcf_8q.png?_i=AA 300w\" sizes=\"auto, (max-width: 3024px) 100vw, 3024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Oruka Therapeutics (ORKA): free cash flow, $ millions, last 7 quarters (to March 31, 2026) (\u003Cstrong>TIKR\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Phase 3 will cost more, though. (And I wouldn’t be surprised to see Oruka pad that cushion after a result like this.)\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">My take: Two trials now back up ORKA-001’s clear-skin numbers. If December shows the response holds on a once-a-year shot, that’s Gelfand’s “paradigm shift,” and there’s plenty of upside from here for a company valued at a little over $5 billion before today.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Of course, these are 16-week results, and Phase 3 hasn’t started yet.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-so-what-is-oruka-therapeutics-stock-actually-worth\" class=\"wp-block-heading\">So what is Oruka Therapeutics stock actually worth?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Oruka Therapeutics could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fvaluation-model-builder?ref=tikrblog\">Value Oruka Therapeutics for free\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>Disclaimer:\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!\u003C\u002Fem>\u003C\u002Fp>\n",758,"en","\u002Fblog\u002Foruka-therapeutics-soars-12-as-psoriasis-drug-clears-skin-in-61-of-high-dose-patients-a-paradigm-shift","oruka-therapeutics-soars-12-as-psoriasis-drug-clears-skin-in-61-of-high-dose-patients-a-paradigm-shift","images\u002Fgrinning-man-with-stubble-fireworks-over-a-city\u002Fgrinning-man-with-stubble-fireworks-over-a-city","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793031595\u002Fimages\u002Fgrinning-man-with-stubble-fireworks-over-a-city\u002Fgrinning-man-with-stubble-fireworks-over-a-city.png?_i=AA",{"altText":237,"imageCredit":238},"Oruka Therapeutics Soars 12% as Psoriasis Drug Clears Skin in 61% of High-Dose Patients: “A Paradigm Shift”","Rido via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Michael Douglass","michaeldouglass","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"David Hanson","davidtikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"General Investing","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Now December has to deliver",{"title":225,"description":258,"twitterTitle":225,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":225,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Est. reading time","5 minutes",1200,630,[266,283,298,313,327],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":280,"relatedPosts":282},"Microsoft, Amazon and Google \"Will Beat Their Numbers\" as a $2 Trillion Cloud Backlog Builds","2026-10-26 17:45:24","Turns out the capacity crunch is the bull case",1037,"\u002Fblog\u002Fmicrosoft-amazon-and-google-will-beat-their-numbers-as-a-2-trillion-cloud-backlog-builds","microsoft-amazon-and-google-will-beat-their-numbers-as-a-2-trillion-cloud-backlog-builds","images\u002Fsmiling-man-arms-crossed-data-center-servers\u002Fsmiling-man-arms-crossed-data-center-servers","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793026755\u002Fimages\u002Fsmiling-man-arms-crossed-data-center-servers\u002Fsmiling-man-arms-crossed-data-center-servers.png?_i=AA",{"altText":267},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":279},"Roxanna Maglangit","roxtikr",[],[281],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":284,"date":285,"excerpt":286,"wordCount":287,"uri":288,"slug":289,"cloudinaryAssetId":290,"featuredImageOriginalUrl":291,"featuredImageMetadata":292,"author":293,"categories":295,"relatedPosts":297},"Chamath: SpaceX's $40 Billion Debt Is \"Better Than Most Sovereign Debt.\" Neoclouds Won't Borrow That Cheap","2026-10-26 17:43:30","That gap is worth billions a year",1031,"\u002Fblog\u002Fchamath-spacexs-40-billion-debt-is-better-than-most-sovereign-debt-neoclouds-wont-borrow-that-cheap","chamath-spacexs-40-billion-debt-is-better-than-most-sovereign-debt-neoclouds-wont-borrow-that-cheap","images\u002Felon-musk-spacex-falcon-9-launch\u002Felon-musk-spacex-falcon-9-launch","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793027310\u002Fimages\u002Felon-musk-spacex-falcon-9-launch\u002Felon-musk-spacex-falcon-9-launch.png?_i=AA",{"altText":284},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":294},[],[296],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":299,"date":300,"excerpt":301,"wordCount":302,"uri":303,"slug":304,"cloudinaryAssetId":305,"featuredImageOriginalUrl":306,"featuredImageMetadata":307,"author":308,"categories":310,"relatedPosts":312},"Apple Hits \"the Highest Valuation Level in Company History\" by Sitting Out the AI Capex Race","2026-10-26 17:43:00","Sometimes the best move is to sit still",913,"\u002Fblog\u002Fapple-hits-the-highest-valuation-level-in-company-history-by-sitting-out-the-ai-capex-race","apple-hits-the-highest-valuation-level-in-company-history-by-sitting-out-the-ai-capex-race","images\u002FApple-Stock_144501592ea\u002FApple-Stock_144501592ea","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792784638\u002Fimages\u002FApple-Stock_144501592ea\u002FApple-Stock_144501592ea.png?_i=AA",{"altText":299},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":309},[],[311],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":314,"date":315,"excerpt":316,"wordCount":317,"uri":318,"slug":319,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":320,"featuredImageMetadata":321,"author":322,"categories":324,"relatedPosts":326},"Musk: Terafab Will Rank in \"Top 20\" GDP From a Single Building","2026-10-26 17:41:55","Ambitious, even by Elon Musk's standards",1052,"\u002Fblog\u002Fmusk-terafab-will-rank-in-top-20-gdp-from-a-single-building","musk-terafab-will-rank-in-top-20-gdp-from-a-single-building","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002FSpaceX-Stock-1-600x400.png",{"altText":314},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":323},[],[325],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":328,"date":329,"excerpt":330,"wordCount":331,"uri":332,"slug":333,"cloudinaryAssetId":334,"featuredImageOriginalUrl":335,"featuredImageMetadata":336,"author":337,"categories":341,"relatedPosts":343},"CACI Gains 6% on Jefferies Upgrade and $281 Million Navy Win as Booz Allen Jumps 7%","2026-10-26 17:35:57","It's all about the margins",722,"\u002Fblog\u002Fcaci-gains-6-on-jefferies-upgrade-and-281-million-navy-win-as-booz-allen-jumps-7","caci-gains-6-on-jefferies-upgrade-and-281-million-navy-win-as-booz-allen-jumps-7","images\u002FRTO-stock-vkstudio-via-Canva_1438100cb89\u002FRTO-stock-vkstudio-via-Canva_1438100cb89","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792699147\u002Fimages\u002FRTO-stock-vkstudio-via-Canva_1438100cb89\u002FRTO-stock-vkstudio-via-Canva_1438100cb89.png?_i=AA",{"altText":328},{"name":338,"slug":339,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":340},"Gian Estrada","giantikr",[],[342],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[345,365,380,394,409,429,444,459,474],{"id":255,"title":346,"date":347,"excerpt":348,"wordCount":349,"uri":350,"slug":351,"cloudinaryAssetId":352,"featuredImageOriginalUrl":353,"featuredImageMetadata":354,"author":355,"categories":359,"relatedPosts":364},"Up 13% In Last 12 Months, Can Arista Networks Stock Give Better Returns in 2026?","2026-10-26 12:57:00","Arista stock is up 10% in a year. See what TIKR’s Valuation Model says about ANET’s upside, with a $275 price target by December 2028.",1099,"\u002Fblog\u002Farista-networks-stock-valuation-anet-2026","arista-networks-stock-valuation-anet-2026","images\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793010558\u002Fimages\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva.png?_i=AA",{"altText":346},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":358},"Aditya Raghunath","adityatikr",[],[360],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},"Valuation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":366,"date":367,"excerpt":368,"wordCount":369,"uri":370,"slug":371,"cloudinaryAssetId":372,"featuredImageOriginalUrl":373,"featuredImageMetadata":374,"author":375,"categories":377,"relatedPosts":379},"Down 48% In Last 12 Months, Can SoFi Stock Give Better Results in 2026?","2026-10-26 12:45:00","SoFi stock is down 51% in a year. See what TIKR’s Valuation Model says about SOFI’s upside, with a $22 price target by December 2028.",1081,"\u002Fblog\u002Fsofi-stock-valuation-sofi-2026","sofi-stock-valuation-sofi-2026","images\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793015325\u002Fimages\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva.png?_i=AA",{"altText":366},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":376},[],[378],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":381,"date":367,"excerpt":382,"wordCount":383,"uri":384,"slug":385,"cloudinaryAssetId":386,"featuredImageOriginalUrl":387,"featuredImageMetadata":388,"author":389,"categories":391,"relatedPosts":393},"Up Just 9% in the Last 12 Months, Can Palantir Stock Give Better Returns in 2026?","Palantir stock is up just 4% in a year. See what TIKR’s Valuation Model says about PLTR’s upside, with a $529 target by December 2028.",1024,"\u002Fblog\u002Fpalantir-stock-valuation-pltr-2026","palantir-stock-valuation-pltr-2026","images\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793003212\u002Fimages\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c.png?_i=AA",{"altText":381},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},[],[392],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":406,"relatedPosts":408},"Down 56% In Last 12 Months, Can AppLovin Stock Give Better Returns in 2026?","2026-10-26 12:33:00","AppLovin stock is down 60% in a year. See what TIKR’s Valuation Model says about APP’s upside, with a $366 price target by December 2028.",1139,"\u002Fblog\u002Fapplovin-stock-valuation-app-2026","applovin-stock-valuation-app-2026","images\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793013215\u002Fimages\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2.png?_i=AA",{"altText":395},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":405},[],[407],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":410,"date":411,"excerpt":412,"wordCount":413,"uri":414,"slug":415,"cloudinaryAssetId":416,"featuredImageOriginalUrl":417,"featuredImageMetadata":418,"author":419,"categories":423,"relatedPosts":428},"ExxonMobil Stock Hit a Record Close as Brent Topped $116. Here’s Where the Stock Could Go by 2030","2026-10-26 07:55:00","ExxonMobil closed at a record $183.21 on October 23 as Brent topped $116, and now trades above the Street’s mean target. Its CFO says Pioneer synergies doubled and Exxon aims to double Permian recovery with fewer wells, a cost lever the company controls.",791,"\u002Fblog\u002Fexxonmobil-stock-hit-a-record-close-as-brent-topped-116-heres-where-the-stock-could-go-by-2030","exxonmobil-stock-hit-a-record-close-as-brent-topped-116-heres-where-the-stock-could-go-by-2030","images\u002F13-10\u002F13-10","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792976181\u002Fimages\u002F13-10\u002F13-10.png?_i=AA",{"altText":410},{"name":420,"slug":421,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":422},"Wiltone Asuncion","wiltonetikr",[],[424],{"name":425,"slug":426,"uri":427,"description":243,"postsCount":255},"Stock Reviews","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":255,"title":430,"date":431,"excerpt":432,"wordCount":433,"uri":434,"slug":435,"cloudinaryAssetId":436,"featuredImageOriginalUrl":437,"featuredImageMetadata":438,"author":439,"categories":441,"relatedPosts":443},"Rivian Hit a 52-Week Low the Day After Buying an AI Simulation Startup. Here’s What October 29 Has to Show","2026-10-26 07:50:00","Rivian touched a 52-week low the day after buying an AI simulation startup, extending a 19% slide that began weeks earlier. The October 29 report now has to show the cost line can carry the autonomy spending.",925,"\u002Fblog\u002Frivian-hit-a-52-week-low-the-day-after-buying-an-ai-simulation-startup-heres-what-october-29-has-to-show","rivian-hit-a-52-week-low-the-day-after-buying-an-ai-simulation-startup-heres-what-october-29-has-to-show","images\u002F12-10_145310df477\u002F12-10_145310df477","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792976166\u002Fimages\u002F12-10_145310df477\u002F12-10_145310df477.png?_i=AA",{"altText":430},{"name":420,"slug":421,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":440},[],[442],{"name":425,"slug":426,"uri":427,"description":243,"postsCount":255},[],{"id":255,"title":445,"date":446,"excerpt":447,"wordCount":448,"uri":449,"slug":450,"cloudinaryAssetId":451,"featuredImageOriginalUrl":452,"featuredImageMetadata":453,"author":454,"categories":456,"relatedPosts":458},"Robinhood Stock Fell 15% in October Before Its Q3 Report. Here’s Where It Could Go by 2030","2026-10-26 07:45:00","Robinhood fell 6.73% in two sessions, in step with Coinbase, before its October 27 report. Two October 22 developments point to crypto activity that may not show up in its crypto revenue line: bitcoin price contracts and Morpho’s first lending markets for its stock tokens.",854,"\u002Fblog\u002Frobinhood-stock-fell-15-in-october-before-its-q3-report-heres-where-it-could-go-by-2030","robinhood-stock-fell-15-in-october-before-its-q3-report-heres-where-it-could-go-by-2030","images\u002F11-11_145309e717b\u002F11-11_145309e717b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792976143\u002Fimages\u002F11-11_145309e717b\u002F11-11_145309e717b.png?_i=AA",{"altText":445},{"name":420,"slug":421,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":455},[],[457],{"name":425,"slug":426,"uri":427,"description":243,"postsCount":255},[],{"id":255,"title":460,"date":461,"excerpt":462,"wordCount":463,"uri":464,"slug":465,"cloudinaryAssetId":466,"featuredImageOriginalUrl":467,"featuredImageMetadata":468,"author":469,"categories":471,"relatedPosts":473},"Walmart Stock Rose 15% in October Without a Higher Earnings Forecast. Here’s Where It Could Go by 2031","2026-10-26 07:40:00","Walmart rose 15.4% from September 30 to October 23, yet analysts’ next-12-months EPS estimate stayed at $3.00 a share. Almost all of the gain came from a higher multiple, ahead of a November 19 report guided to 0% to 3% EPS growth.",832,"\u002Fblog\u002Fwalmart-stock-rose-15-in-october-without-a-higher-earnings-forecast-heres-where-it-could-go-by-2031","walmart-stock-rose-15-in-october-without-a-higher-earnings-forecast-heres-where-it-could-go-by-2031","images\u002F10-14_145308a5c00\u002F10-14_145308a5c00","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792976123\u002Fimages\u002F10-14_145308a5c00\u002F10-14_145308a5c00.png?_i=AA",{"altText":460},{"name":420,"slug":421,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":470},[],[472],{"name":425,"slug":426,"uri":427,"description":243,"postsCount":255},[],{"id":255,"title":475,"date":476,"excerpt":477,"wordCount":478,"uri":479,"slug":480,"cloudinaryAssetId":481,"featuredImageOriginalUrl":482,"featuredImageMetadata":483,"author":484,"categories":486,"relatedPosts":488},"Apple Briefly Topped Nvidia as Nvidia’s Slide Reached 12%. Here’s Where Apple Stock Could Go by 2030","2026-10-26 07:35:00","Apple briefly passed Nvidia as the world’s most valuable company on October 23, hitting a record $351.73. Its AI strategy needs little capex, but at 38 times earnings, the November 2 margin print carries the multiple.",845,"\u002Fblog\u002Fapple-briefly-topped-nvidia-as-nvidias-slide-reached-12-heres-where-apple-stock-could-go-by-2030","apple-briefly-topped-nvidia-as-nvidias-slide-reached-12-heres-where-apple-stock-could-go-by-2030","images\u002F9-15_1453077213e\u002F9-15_1453077213e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792976106\u002Fimages\u002F9-15_1453077213e\u002F9-15_1453077213e.png?_i=AA",{"altText":475},{"name":420,"slug":421,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":485},[],[487],{"name":425,"slug":426,"uri":427,"description":243,"postsCount":255},[]]